SMA research
↗SAPPHIRE apitegromab trial: results and interpretation
Read the SMA population, motor-function outcome, pooled effect estimate, and later FDA-label context of SAPPHIRE.
An evidence-led research libraryThe science of
The science of
myostatin inhibition.
Read the biology and human research behind myostatin inhibitors. Explore clinical study summaries with the population, outcome, and limitations in view.
Open the research library Understand the pathwayFrom mechanism to medicineMSTN
BiologyWhat the pathway does
TrialsWhat people experienced
InterpretationWhat the result supports
A reading room for clinical evidence.
Source-linked. Context included.
01 Exact compound02 Human context03 Measured outcome04 Source & limitations
The question behind the fieldCan changing a muscle signal
Can changing a muscle signal
improve a clinical outcome?
Myostatin is a regulator of skeletal-muscle growth. The research challenge is to turn that biological insight into a benefit that matters to people.
That requires more than a larger muscle measurement. A useful reading of the evidence keeps the intervention, participant group, endpoint, and safety findings together.
How to read a myostatin trial →Selected studies, explained
View the full library →Read the finding. Keep the context.
Body composition
↗BELIEVE trial: bimagrumab and semaglutide in obesity
A guide to the 2026 phase 2 publication, selected weight-change results, combination-treatment context, and limitations.
Emerging findings
↗COURAGE trevogrumab results: DXA and MRI are different
Interpret the October 2026 sponsor report without confusing whole-body lean-mass change with thigh-muscle preservation.
Body composition
↗Bimagrumab 2021 trial: fat mass, lean mass, and body weight
Read the 48-week phase 2 results while keeping fat loss, total weight loss, and lean-tissue change separate.
A recent development
From a trial result to a defined indication.
SAPPHIRE is a useful case study in reading evidence precisely: a defined SMA population, a motor-function scale, a prespecified analysis, and a later FDA approval with its own label.
Read the SAPPHIRE analysis →Methods matter
Lean mass is not a functional test.
DXA, MRI, strength testing, and motor-function scales answer different questions. Keep their units and denominators attached to every numerical claim.
Learn to read the endpoints →Questions, answered.
What does this library cover?
It covers the myostatin pathway and selected human studies, including SMA and body-composition research. Each study page separates the reported findings from editorial interpretation.
Does the .org address mean this is a nonprofit?
No. This is a privately owned educational publication. See about and ownership for its relationship to the other two publications.
How do you distinguish evidence from interpretation?
Original sources are linked on each article. Study facts are described with their population and timeframe; reading guidance explains what those facts can and cannot support. See the editorial policy.